CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 63 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,875,456 | +37.9% | 1,505,976 | +100.8% | 0.08% | +44.2% |
| Q2 2023 | $23,842,500 | +145.3% | 750,000 | +88.2% | 0.05% | +136.4% |
| Q1 2023 | $9,719,903 | -22.7% | 398,520 | 0.0% | 0.02% | -26.7% |
| Q4 2022 | $12,569,321 | +11.6% | 398,520 | 0.0% | 0.03% | +7.1% |
| Q3 2022 | $11,262,000 | +33.1% | 398,520 | +24.5% | 0.03% | +47.4% |
| Q2 2022 | $8,461,000 | -39.6% | 320,000 | -20.0% | 0.02% | -29.6% |
| Q1 2022 | $14,004,000 | +39.3% | 400,000 | +29.0% | 0.03% | +50.0% |
| Q4 2021 | $10,050,000 | +36.3% | 310,000 | +24.0% | 0.02% | +20.0% |
| Q3 2021 | $7,375,000 | -42.4% | 250,000 | -50.0% | 0.02% | -40.0% |
| Q2 2021 | $12,810,000 | +55.5% | 500,000 | -16.7% | 0.02% | +47.1% |
| Q1 2021 | $8,238,000 | -17.2% | 600,000 | 0.0% | 0.02% | -22.7% |
| Q4 2020 | $9,948,000 | – | 600,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |